Shirley Lehnert

Radiosensitizers and Radiochemotherapy in the Treatment of Cancer (eBook, PDF)

• Format: PDF

Produktbeschreibung

This book gathers into a single volume the most up-to-date information on radiosensitizing drugs, the mechanisms of radiosensitization, and the clinical applications of this treatment modality. Written for radiation oncologists, medical oncologists, graduate students and residents in various branches of oncology, the text details a range of agents and treatment pathways. Intuitively organized by topic and application, it includes the latest clinical trials, extensive illustrations, and a wealth of references.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Taylor & Francis
• Seitenzahl: 548
• Erscheinungstermin: 8. Dezember 2014
• Englisch
• ISBN-13: 9781439829035
• Artikelnr.: 42013451

Autorenporträt

Shirley Lehnert is currently a professor in the Department of Oncology at McGill University in Montreal, Quebec, Canada. She graduated from London University in the UK with a PhD in biophysics. Dr. Lehnert did postdoctoral work at the University of Rochester. She conducted research in radiobiology and biophysics first at Sloane Kettering Institute and then at the Radiological Research Laboratory of Columbia University in New York. Dr. Lehnert has published extensively in the fields of radiation biology, tumor biology, and drug delivery.

Inhaltsangabe

Radiosensitization and Chemoradiation. Radiosensitization by Oxygen and
Nitric Oxide. Radioenhancement by Targeting Cellular Redox Pathways and/or
by Incorporation of High-Z Materials into the Target. Radiosensitization by
Halogenated Pyrimidines. Radiosensitization by Antimetabolites.
Radiosensitization by Platinum Drugs and Alkylating Agents. Topoisomerase
Inhibitors and Microtubule-Targeting Agents. Targeting the DNA Damage
Response: ATM, p53, Checkpoints, and the Proteasome. Radiosensitization by
Inhibition of DNA Repair. Targeting Growth Factor Receptors for
Radiosensitization. Targeting Signaling Molecules for Radiosensitization.
Radiosensitization by Targeting the Tumor Microenvironment. Phytochemicals:
Chemopreventive, Radiosensitizing, Radioprotective. Delivery Methods for
Radioenhancing Drugs.